Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies

Na minha lista:

Detalhes bibliográficos
Autor principal:	Long Jiang (14956159) (author)
Outros Autores:	Katrine Ingelshed (14956162) (author), Yunbing Shen (14956165) (author), Sanjaykumar V. Boddul (14956168) (author), Vaishnavi Srinivasan Iyer (14956171) (author), Zsolt Kasza (14956174) (author), Saikiran Sedimbi (14956177) (author), David P. Lane (128368) (author), Fredrik Wermeling (14956180) (author)
Publicado em:	2025
Assuntos:	Cancer Cancer Biology Molecular and Cellular Biology Therapeutic Research and Development DNA Damage and Repair Drug Targets Oncoprotein & tumor suppressor drug targets Oncogenes & Tumor Suppressors p53
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!

_version_	1849927640295669760
author	Long Jiang (14956159)
author2	Katrine Ingelshed (14956162) Yunbing Shen (14956165) Sanjaykumar V. Boddul (14956168) Vaishnavi Srinivasan Iyer (14956171) Zsolt Kasza (14956174) Saikiran Sedimbi (14956177) David P. Lane (128368) Fredrik Wermeling (14956180)
author2_role	author author author author author author author author
author_facet	Long Jiang (14956159) Katrine Ingelshed (14956162) Yunbing Shen (14956165) Sanjaykumar V. Boddul (14956168) Vaishnavi Srinivasan Iyer (14956171) Zsolt Kasza (14956174) Saikiran Sedimbi (14956177) David P. Lane (128368) Fredrik Wermeling (14956180)
author_role	author
dc.creator.none.fl_str_mv	Long Jiang (14956159) Katrine Ingelshed (14956162) Yunbing Shen (14956165) Sanjaykumar V. Boddul (14956168) Vaishnavi Srinivasan Iyer (14956171) Zsolt Kasza (14956174) Saikiran Sedimbi (14956177) David P. Lane (128368) Fredrik Wermeling (14956180)
dc.date.none.fl_str_mv	2025-11-24T22:02:07Z
dc.identifier.none.fl_str_mv	10.1158/0008-5472.30698664
dc.relation.none.fl_str_mv	https://figshare.com/articles/dataset/Supplementary_Table_from_CRISPR_Cas9-Induced_DNA_Damage_Enriches_for_Mutations_in_a_p53-Linked_Interactome_Implications_for_CRISPR-Based_Therapies/30698664
dc.rights.none.fl_str_mv	CC BY info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv	Cancer Cancer Biology Molecular and Cellular Biology Therapeutic Research and Development DNA Damage and Repair Drug Targets Oncoprotein & tumor suppressor drug targets Oncogenes & Tumor Suppressors p53
dc.title.none.fl_str_mv	Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies
dc.type.none.fl_str_mv	Dataset info:eu-repo/semantics/publishedVersion dataset
description	Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies
eu_rights_str_mv	openAccess
id	Manara_e356eb28e2e15fec3959de2e36078853
identifier_str_mv	10.1158/0008-5472.30698664
network_acronym_str	Manara
network_name_str	ManaraRepo
oai_identifier_str	oai:figshare.com:article/30698664
publishDate	2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv	CC BY
spelling	Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based TherapiesLong Jiang (14956159)Katrine Ingelshed (14956162)Yunbing Shen (14956165)Sanjaykumar V. Boddul (14956168)Vaishnavi Srinivasan Iyer (14956171)Zsolt Kasza (14956174)Saikiran Sedimbi (14956177)David P. Lane (128368)Fredrik Wermeling (14956180)CancerCancer BiologyMolecular and Cellular BiologyTherapeutic Research and DevelopmentDNA Damage and RepairDrug TargetsOncoprotein & tumor suppressor drug targetsOncogenes & Tumor Suppressorsp53Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies2025-11-24T22:02:07ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/0008-5472.30698664https://figshare.com/articles/dataset/Supplementary_Table_from_CRISPR_Cas9-Induced_DNA_Damage_Enriches_for_Mutations_in_a_p53-Linked_Interactome_Implications_for_CRISPR-Based_Therapies/30698664CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/306986642025-11-24T22:02:07Z
spellingShingle	Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies Long Jiang (14956159) Cancer Cancer Biology Molecular and Cellular Biology Therapeutic Research and Development DNA Damage and Repair Drug Targets Oncoprotein & tumor suppressor drug targets Oncogenes & Tumor Suppressors p53
status_str	publishedVersion
title	Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies
title_full	Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies
title_fullStr	Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies
title_full_unstemmed	Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies
title_short	Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies
title_sort	Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies
topic	Cancer Cancer Biology Molecular and Cellular Biology Therapeutic Research and Development DNA Damage and Repair Drug Targets Oncoprotein & tumor suppressor drug targets Oncogenes & Tumor Suppressors p53

Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies

Registos relacionados